FMO5 and Nephropathy: STZ damages the DNA of the pancreatic-β cells and triggers multiple pathways, including activation of protein kinase-C, poly (ADP-ribose) polymerase and NAD(P)H oxidase, with consequent generation of ROS and advanced glycation end products resulting in renal damage and nephropathy [25–27].